Efficacy of SGLT2 inhibitors as additional treatment in Japanese type 2 diabetic patients: second or third choice?

Abstract Objectives Due to the increase of type 2 diabetes (T2D), the number of patients in treatment with multiple anti-diabetic agents is increased. According to the recent recommendation of treatment guidelines, sodium-glucose cotransporter 2 (SGLT2) inhibitors would be used as additional treatme...

Full description

Bibliographic Details
Main Authors: Makoto Fujiwara, Masaru Shimizu, Yuko Maejima, Kenju Shimomura
Format: Article
Language:English
Published: BMC 2022-03-01
Series:BMC Research Notes
Subjects:
Online Access:https://doi.org/10.1186/s13104-022-06010-6